Value of common stock issued as a result of the exercise of warrants.

No definition available.

Name:	aphb_CommonStockIssuedDuringPeriodValueWarrantsExercised
Namespace Prefix:	aphb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Fair value of derivative liability of warrants as of the balance sheet date.

+ References

No definition available.

+ Details

Name:	aphb_DerivativeWarrantsLiability
Namespace Prefix:	aphb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

This element represents that, the exercise price of stock issued during the period.

+ References

No definition available.

+ Details

Name:	aphb_StockIssuedDuringPeriodExercisePriceNewIssues2
Namespace Prefix:	aphb_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of new stock issued during the period.

+ References

No definition available.

+ Details

Name:	aphb_StockIssuedDuringPeriodSharesNewIssues2
Namespace Prefix:	aphb_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of warrants exercised during the period.

+ References

No definition available.

+ Details

Name:	aphb_WarrantsExercisedDuringPeriodValue
Namespace Prefix:	aphb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

This element represents that, the warrants issuance costs for during the period.

+ References

No definition available.

+ Details

Name:	aphb_WarrantsIssuanceCosts
Namespace Prefix:	aphb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

This element represents that, the exercise price of warrants issued during the period.

+ References

No definition available.

+ Details

Name:	aphb_WarrantsIssuedDuringPeriodExercisePriceOfWarrants
Namespace Prefix:	aphb_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

This element represents that, the number of warrants issued during the period.

+ References

No definition available.

+ Details

Name:	aphb_WarrantsIssuedDuringPeriodNumberOfWarrants
Namespace Prefix:	aphb_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

This element represents the warrants issued during the period, terms of expiration.

+ References

No definition available.

+ Details

Name:	aphb_WarrantsIssuedDuringPeriodTermsOfExpiration
Namespace Prefix:	aphb_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of increase in the fair value of derivatives recognized in the income statement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5618551-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (a),(c),(d),(e)

-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624171-113959

+ Details

Name:	us-gaap_DerivativeGainOnDerivative
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 40

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6445032&loc=d3e90193-114008

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 480

-SubTopic 10

-Section S99

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

+ Details

Name:	us-gaap_ReclassificationsOfTemporaryToPermanentEquity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aphb_BiocontrolLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=aphb_WarrantsIssuedOnJune262013MemberMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=aphb_SeriesBConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Warrants and Warrants Liability (Details Textual) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2011
Class of Warrant or Right [Line Items]
Derivative warrants liability	$ 6,035,000aphb_DerivativeWarrantsLiability	16,871,000aphb_DerivativeWarrantsLiability
Derivative, Gain on Derivative	7,100,000us-gaap_DerivativeGainOnDerivative
Warrants Issued on June 26, 2013 Member [Member]
Class of Warrant or Right [Line Items]
Warrants Issued During the Period, Number of Warrants		28,394,834
Warrants Exercised During Period Value	3,855,714
Common Stock Issued During Period Value Warrants Exercised	2,734,151
Reclassifications of Temporary to Permanent Equity	1,594,000
Biocontrol Limited [Member]
Class of Warrant or Right [Line Items]
Warrants Issued During the Period, Terms Of Expiration			December 2016
Warrants Issued During the Period, Number of Warrants			1,355,164
Warrants Issued During the Period, Exercise Price of Warrants			$ 0.46
Convertible Notes Payable [Member]
Class of Warrant or Right [Line Items]
Warrants Issued During the Period, Terms Of Expiration		February through May 2018
Warrants Issued During the Period, Number of Warrants		7,030,387
Warrants Issued During the Period, Exercise Price of Warrants		0.14
Series B Convertible Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Warrants Issued During the Period, Number of Warrants		12,499,996
Warrants Issued During the Period, Exercise Price of Warrants		0.14
Common Stock [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues2		72,007,000
Warrants Issued During the Period, Number of Warrants		4,320,420
Warrants Issued During the Period, Exercise Price of Warrants		0.25
Private Placement [Member] \| Series B Convertible Preferred Stock [Member]
Class of Warrant or Right [Line Items]
Warrants Issued During the Period, Terms Of Expiration		June 2018
Warrants Issued During the Period, Number of Warrants		30,040,195
Warrants Issued During the Period, Exercise Price of Warrants		0.14
Warrants Issuance Costs		1,400,000
Private Placement [Member] \| Common Stock [Member]
Class of Warrant or Right [Line Items]
Stock Issued During Period, Shares, New Issues2		72,007,000
Stock Issued During Period, Exercise Price, New Issues2		0.25
Warrants Issued During the Period, Terms Of Expiration		December 2018